SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX, Generic Giant

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: El Swiggum who wrote (139)4/1/1997 9:31:00 PM
From: MD Payne   of 212
 
<<Is there a possibility that IVX could go belly-up? Any thoughts?>>

BBC was apparently looking for a song and a dance purchase instead of what might be considered a common sense approach purchase to realize a very valuable and realistic future compliment ..... While any company has the potential to falter, IVAX has recorded recent earnings progress which basically beat street estimates (Too bad they were tied to BBC at release time). In essence, IVAX's pricing as a standalone should easily exceed the current market sell-off/bargain pricing, not to mention the potentially excessive future takeover benefit for the right suitor.

This is my opinion and not only my opinion - - - - no solication is intended because I like the stock, own the stock, and plan to buy more - - - whether El Swiggum is your real name or not!

mdp
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext